94. Primary sclerosing cholangitis
134 clinical trials,   105 drugs   (DrugBank: 37 drugs),   18 drug target genes,   131 drug target pathways

Searched query = "Primary sclerosing cholangitis", "PSC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000021411
2016/04/0101/04/2016clinical efficacy of oral administration of metronidazole in the treatment of primary sclerosing cholangitisclinical efficacy of oral administration of metronidazole in the treatment of primary sclerosing cholangitis - clinical efficacy of oral administration of metronidazole in the treatment of PSC primary sclerosing cholangitisPatients take metronidazole 250mg orally three times day for 3 weeks.Keio University, School of MedicineNULLComplete: follow-up complete16years-oldNot applicableMale and Female20Not applicableJapan
2NCT03069976
(ClinicalTrials.gov)
January 201628/2/2017Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Modification With Antibiotics in ChildrenPrimary Sclerosing Cholangitis;Autoimmune Hepatitis;Overlap SyndromeDrug: MetronidazoleCliniques universitaires Saint-Luc- Université Catholique de LouvainNULLRecruiting3 Years25 YearsAll20N/ABelgium
3NCT01085760
(ClinicalTrials.gov)
February 201010/3/2010A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing CholangitisA Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing CholangitisPrimary Sclerosing CholangitisDrug: Vancomycin;Drug: MetronidazoleMayo ClinicPSC Partners Seeking a Cure FoundationCompleted18 Years75 YearsAll35Phase 1United States